SSTR2 and neuroendocrine neoplasm: In another study, docking was performed by the Tripos Surflex-Dock [25] module with different binding poses of a selected ligand and SSTR2, one of the five subtypes of somatostatin receptors overexpressed in many neuroendocrine tumors [26].